Louis Kayitalire

2019

In 2019, Louis Kayitalire earned a total compensation of $739.8K as Chief Medical Officer at F-star Therapeutics.

Compensation breakdown

Option Awards$521,523
Salary$200,000
Other$18,272
Total$739,795

Kayitalire received $521.5K in option awards, accounting for 70% of the total pay in 2019.

Kayitalire also received $200K in salary and $18.3K in other compensation.

Rankings

In 2019, Louis Kayitalire's compensation ranked 10,513th out of 13,971 executives tracked by ExecPay. In other words, Kayitalire earned more than 24.8% of executives.

ClassificationRankingPercentile
All
10,513
out of 13,971
25th
Division
Manufacturing
4,249
out of 5,701
26th
Major group
Chemicals And Allied Products
1,646
out of 2,200
25th
Industry group
Drugs
1,411
out of 1,886
25th
Industry
Pharmaceutical Preparations
1,046
out of 1,398
25th
Source: SEC filing on April 7, 2021.

Kayitalire's colleagues

We found six more compensation records of executives who worked with Louis Kayitalire at F-star Therapeutics in 2019.

2019

Eliot Forster

F-star Therapeutics

Chief Executive Officer

2019

Martin Driscoll

F-star Therapeutics

Chief Executive Officer

2019

Jonathan Freve

F-star Therapeutics

Chief Financial Officer

2019

RP Iyer

F-star Therapeutics

Chief Scientific Officer

2019

Darlene Deptula-Hicks

F-star Therapeutics

Chief Financial Officer

2019

Neil Brewis

F-star Therapeutics

Chief Scientific Officer

News

In-depth

You may also like